<?xml version="1.0" encoding="UTF-8"?>
<p>Despite a 13-fold decrease in the epidemic haemorrhagic fever notification rate since 1987 and continuous decline in the disease-specific mortality rate, China is still the country most severely affected by this disease, with 90% of the global cases of haemorrhagic fever with renal syndrome (HFRS) occurring in China 
 <xref rid="pone.0031076-Guan1" ref-type="bibr">[13]</xref>, 
 <xref rid="pone.0031076-Fang1" ref-type="bibr">[14]</xref>. HFRS remains an important public health issue in China, as an estimated 20,000–50,000 new cases are reported each year 
 <xref rid="pone.0031076-Fang2" ref-type="bibr">[15]</xref>. It is important to establish effective strategies to reduce the incidence of HFRS. The mean annual decline in mortality due to this disease is 12% (95% CI, 3–20%, 
 <xref ref-type="table" rid="pone-0031076-t002">Table 2</xref>).
</p>
